Tampa, FL– Robert J. Gillies, Ph.D., has been chosen as the president-elect for The Society for Molecular Imaging. The world-renowned society strives to advance the understanding of biology and medicine by studying noninvasive, in-vivo molecular events in healthy and diseased processes.
Gillies accepted the position at the society’s council meeting Friday in Montreal. “I’m honored to be involved with such a prestigious organization,” Gillies said. “During my tenure as president, I hope to initiate establishment of Web-based curricula for teaching of molecular imaging to new researchers.”
Gillies is the vice chair of Radiology Research and the director of Molecular & Functional Imaging at Moffitt. His research is focused on the use of noninvasive imaging for cancer therapy.
He is working on translational research in the areas of the use of therapy biomarkers to monitor and predict response; the tumor microenvironment and its effects on tumor progression; and the development of targeted imaging therapeutic chemicals.
Gillies was honored by the Academy of Molecular Imaging as a Distinguished Basic Scientist recipient in June for his extensive research, which has contributed to the advancement in the field of molecular imaging.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.